Resolution of bronchomalacia presenting as severe asthma by endoscopic intervention.

1. National Vaccine Injury Compensation Program, Vaccine Injury Table. http:// www.hrsa.gov/vaccinecompensation/table.htm. Accessed October 12, 2010. 2. Somsak JG, Johann-Liang R. Charge to the Committee. http://www8. nationalacademies.org/cp/meetingview.aspx?MeetingID 3398&MeetingNo 1. Accessed October 12, 2010. 3. Ruggeberg JU, Gold MS, Bayas JM, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25:5675–5684. 4. National Vaccine Injury Compensation Program, Statistics Reports. http:// www.hrsa.gov/vaccinecompensation/statistics_report.htm. Accessed October 12, 2010. 5. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59:695–703. 6. Pool V, Braun MM, Kelso JM, et al. Prevalence of anti-gelatin IGE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics. 2002;110:e71. 7. Bohlke K, Davie RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112:815–820.